Update regarding Elicera Therpeutics ticker ELIC:
-
Update regarding Elicera Therpeutics ticker ELIC, see previous thread from 31/10 about the company:
First patient in on ELC-301 has completed and interim results of three patients is due Q1-2025, where safety and effect will already be measured, so according to CEO we might already see the anti-tumor effect at lowest dosage, which will be a high share price driver, and a 5 x share price rally H1 2025 would be possible given the already low valuation of the company.
here is link in Swedish where CEO presents the company and the latest clinical trial.
Link in swedish to interview with CEO where he is very optimistic about the company.
https://discord.gg/SzwSQFE6SC link to community.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind